Increased White Matter Aerobic Glycolysis in Multiple Sclerosis

Overview

Journal Ann Neurol

Specialty Neurology

Date 2024 Dec 23

PMID 39714123

Authors

Matthew R Brier

Bradley Judge

Chunwei Ying

Amber Salter

Hongyu An

Aakash Patel

Qing Wang

Yong Wang

Anne H Cross

Robert T Naismith

Tammie Ls Benzinger

Manu S Goyal

Affiliations

Soon will be listed here.

Abstract

Objective: Despite treatments which reduce relapses in multiple sclerosis (MS), many patients continue to experience progressive disability accumulation. MS is associated with metabolic disruptions and cerebral metabolic stress predisposes to tissue injury and possibly impaired remyelination. Additionally, myelin homeostasis is metabolically expensive and reliant on glycolysis. We investigated cerebral metabolic changes in MS and when in the disease course they occurred, and assessed their relationship with microstructural changes.

Methods: This study used combined fluorodeoxyglucose (FDG) positron emission tomography (PET) and magnetic resonance imaging (MRI) to measure cerebral metabolic rate of glucose and oxygen, thereby quantifying glycolysis. Twelve healthy controls, 20 patients with relapsing MS, and 13 patients with non-relapsing MS were studied. Relapsing patients with MS were treatment naïve and scanned pre- and post-initiation of high efficacy disease modifying therapy.

Results: In normal appearing white matter, we observed increased glucose utilization and reduced oxygen utilization in newly diagnosed MS, consistent with increased glycolysis. Increased glycolysis was greater in patients with a longer disease duration course and higher disability. Among newly diagnosed patients, different treatments had differential impacts on glucose utilization. Last, whereas hypermetabolism within lesions was clearly associated with inflammation, no such relationship was found within normal appearing white matter.

Interpretation: Increased white matter glycolysis is a prominent feature of cerebral metabolism in MS. It begins early in the disease course, increases with disease duration and is independent of microstructural evidence of inflammation in normal appearing white matter. Optimization of the metabolic environment may be an important component of therapies designed to reduce progressive disability. ANN NEUROL 2025;97:766-778.

References

Simons M, Nave K . Oligodendrocytes: Myelination and Axonal Support. Cold Spring Harb Perspect Biol. 2015; 8(1):a020479. PMC: 4691794. DOI: 10.1101/cshperspect.a020479. View

An H, Lin W . Impact of intravascular signal on quantitative measures of cerebral oxygen extraction and blood volume under normo- and hypercapnic conditions using an asymmetric spin echo approach. Magn Reson Med. 2003; 50(4):708-16. DOI: 10.1002/mrm.10576. View

Sun X, Tanaka M, Kondo S, Okamoto K, Hirai S . Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med. 1998; 12(2):89-94. DOI: 10.1007/BF03164835. View

Kappos L, Wolinsky J, Giovannoni G, Arnold D, Wang Q, Bernasconi C . Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials. JAMA Neurol. 2020; 77(9):1132-1140. PMC: 7281382. DOI: 10.1001/jamaneurol.2020.1568. View

Mahad D, Trapp B, Lassmann H . Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015; 14(2):183-93. DOI: 10.1016/S1474-4422(14)70256-X. View

Harris J, Attwell D . The energetics of CNS white matter. J Neurosci. 2012; 32(1):356-71. PMC: 3272449. DOI: 10.1523/JNEUROSCI.3430-11.2012. View

Tremlett H, Zhao Y, Devonshire V . Natural history of secondary-progressive multiple sclerosis. Mult Scler. 2008; 14(3):314-24. DOI: 10.1177/1352458507084264. View

Soto-Heredero G, Gomez de Las Heras M, Gabande-Rodriguez E, Oller J, Mittelbrunn M . Glycolysis - a key player in the inflammatory response. FEBS J. 2020; 287(16):3350-3369. PMC: 7496292. DOI: 10.1111/febs.15327. View

Portaccio E, Bellinvia A, Fonderico M, Pasto L, Razzolini L, Totaro R . Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study. Brain. 2022; 145(8):2796-2805. DOI: 10.1093/brain/awac111. View

10.

Gerevich Z, Kovacs R, Liotta A, Hasam-Henderson L, Weh L, Wallach I . Metabolic implications of axonal demyelination and its consequences for synchronized network activity: An and study. J Cereb Blood Flow Metab. 2023; 43(9):1571-1587. PMC: 10414014. DOI: 10.1177/0271678X231170746. View

11.

Dobson R, Giovannoni G . Multiple sclerosis - a review. Eur J Neurol. 2018; 26(1):27-40. DOI: 10.1111/ene.13819. View

12.

Mahad D, Ziabreva I, Campbell G, Lax N, White K, Hanson P . Mitochondrial changes within axons in multiple sclerosis. Brain. 2009; 132(Pt 5):1161-74. PMC: 3605917. DOI: 10.1093/brain/awp046. View

13.

Bakshi R, Miletich R, Kinkel P, Emmet M, KINKEL W . High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging. 1998; 8(4):228-34. DOI: 10.1111/jon199884228. View

14.

Sattarivand M, Kusano M, Poon I, Caldwell C . Symmetric geometric transfer matrix partial volume correction for PET imaging: principle, validation and robustness. Phys Med Biol. 2012; 57(21):7101-16. DOI: 10.1088/0031-9155/57/21/7101. View

15.

Yu Y, Herman P, Rothman D, Agarwal D, Hyder F . Evaluating the gray and white matter energy budgets of human brain function. J Cereb Blood Flow Metab. 2017; 38(8):1339-1353. PMC: 6092772. DOI: 10.1177/0271678X17708691. View

16.

Goyal M, Blazey T, Metcalf N, McAvoy M, Strain J, Rahmani M . Brain aerobic glycolysis and resilience in Alzheimer disease. Proc Natl Acad Sci U S A. 2023; 120(7):e2212256120. PMC: 9963219. DOI: 10.1073/pnas.2212256120. View

17.

Stark H, Fichtner M, Konig R, Lorkowski S, Schuster S . Causes of upregulation of glycolysis in lymphocytes upon stimulation. A comparison with other cell types. Biochimie. 2015; 118:185-94. DOI: 10.1016/j.biochi.2015.09.017. View

18.

Zhang D, Raichle M . Disease and the brain's dark energy. Nat Rev Neurol. 2010; 6(1):15-28. DOI: 10.1038/nrneurol.2009.198. View

19.

Ge Y, Zhang Z, Lu H, Tang L, Jaggi H, Herbert J . Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI. J Cereb Blood Flow Metab. 2012; 32(3):403-12. PMC: 3293125. DOI: 10.1038/jcbfm.2011.191. View

20.

DASTUR D . Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia. J Cereb Blood Flow Metab. 1985; 5(1):1-9. DOI: 10.1038/jcbfm.1985.1. View